Emerging Organs Biopico Systems operates in the cutting edge field of multi-organ microphysiological systems and OrganRX, presenting a clear upsell path to biopharma R&D teams seeking advanced in vitro models for toxicity, pharmacology, and disease pathology studies.

Toxicology Focus The OrganRX plate enables unidirectional gravity-driven flow for multi-organ integration, positioning Biopico as a strong partner for toxicity screening and precision in vitro studies sought by drug discovery programs.

Size & Growth With a small team size and revenue in the low-to-mid millions, Biopico presents an opportunity for strategic partnerships, pilot projects, or channel partnerships to scale early customer wins and demonstrate value to larger players in biotech.

Tech Stack Fit Biopico leverages common enterprise platforms (AWS, WordPress, HubSpot, iCIMS, Microsoft 365) which can facilitate quick onboarding, CRM-driven outreach, and scalable digital marketing campaigns targeting biotech researchers and procurement teams.

Market Positioning Operating in a landscape with peers like Bio-Rad, Thermo Fisher, Illumina, and others suggests a path for collaboration or alliance opportunities to access broader distribution channels, academic collaborations, and potential co-development deals.